Compared with the usual care group , those in the SMART group showed higher adherence to statins ( 56 % versus 33 % ; P = 0.006 ) but no difference in adherence to antiplatelet ( 81 % versus 75 % ; P = 0.088 ) , antihypertensive ( 67 % versus 69 % ; P = 0.661 ) , or diabetes mellitus drugs ( 73 % versus 67 % ; P = 0.297 ) .